MAPT and Alzheimer disease: Similarities in the molecular targets of 11C-PBB3 and 11C-AZD2184 indicate limited specificity of 11C-PBB3 for tau and a potential binding affinity of the tracer for the more abundant (in the AD brain) amyloid-beta.